BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35131384)

  • 1. DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer.
    Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
    Cancer Lett; 2022 Apr; 532():215585. PubMed ID: 35131384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
    Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
    Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration.
    Liu C; Li Y; Xing Y; Cao B; Yang F; Yang T; Ai Z; Wei Y; Jiang J
    J Biol Chem; 2016 Jul; 291(30):15540-50. PubMed ID: 27226554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.
    Shen J; Xu L; Owonikoko TK; Sun SY; Khuri FR; Curran WJ; Deng X
    Cancer Lett; 2012 May; 318(1):106-13. PubMed ID: 22178655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.
    Schlaepfer DD; Broome MA; Hunter T
    Mol Cell Biol; 1997 Mar; 17(3):1702-13. PubMed ID: 9032297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.
    Wilson C; Nicholes K; Bustos D; Lin E; Song Q; Stephan JP; Kirkpatrick DS; Settleman J
    Oncotarget; 2014 Sep; 5(17):7328-41. PubMed ID: 25193862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src.
    Schlaepfer DD; Hunter T
    J Biol Chem; 1997 May; 272(20):13189-95. PubMed ID: 9148935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling.
    Zhengfu H; Hu Z; Huiwen M; Zhijun L; Jiaojie Z; Xiaoyi Y; Xiujun C
    Biochem Biophys Res Commun; 2015 Aug; 464(2):422-7. PubMed ID: 26102035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
    J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.
    Calalb MB; Polte TR; Hanks SK
    Mol Cell Biol; 1995 Feb; 15(2):954-63. PubMed ID: 7529876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells.
    Park HB; Golubovskaya V; Xu L; Yang X; Lee JW; Scully S; Craven RJ; Cance WG
    Biochem J; 2004 Mar; 378(Pt 2):559-67. PubMed ID: 14629195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases.
    Schaller MD; Hildebrand JD; Parsons JT
    Mol Biol Cell; 1999 Oct; 10(10):3489-505. PubMed ID: 10512882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
    Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
    Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
    Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3.
    Zhou D; Liu T; Rao X; Jie X; Chen Y; Wu Z; Deng H; Zhang D; Wang J; Wu G
    Thorac Cancer; 2023 May; 14(13):1179-1191. PubMed ID: 36965165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.